These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 28641926)
41. Restrained Th17 response and myeloid cell infiltration into the central nervous system by human decidua-derived mesenchymal stem cells during experimental autoimmune encephalomyelitis. Bravo B; Gallego MI; Flores AI; Bornstein R; Puente-Bedia A; Hernández J; de la Torre P; García-Zaragoza E; Perez-Tavarez R; Grande J; Ballester A; Ballester S Stem Cell Res Ther; 2016 Mar; 7():43. PubMed ID: 26987803 [TBL] [Abstract][Full Text] [Related]
42. Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis. Theien BE; Vanderlugt CL; Eagar TN; Nickerson-Nutter C; Nazareno R; Kuchroo VK; Miller SD J Clin Invest; 2001 Apr; 107(8):995-1006. PubMed ID: 11306603 [TBL] [Abstract][Full Text] [Related]
43. The role of dendritic cells in CNS autoimmunity. Zozulya AL; Clarkson BD; Ortler S; Fabry Z; Wiendl H J Mol Med (Berl); 2010 Jun; 88(6):535-44. PubMed ID: 20217033 [TBL] [Abstract][Full Text] [Related]
44. CSF-1 maintains pathogenic but not homeostatic myeloid cells in the central nervous system during autoimmune neuroinflammation. Hwang D; Seyedsadr MS; Ishikawa LLW; Boehm A; Sahin Z; Casella G; Jang S; Gonzalez MV; Garifallou JP; Hakonarson H; Zhang W; Xiao D; Rostami A; Zhang GX; Ciric B Proc Natl Acad Sci U S A; 2022 Apr; 119(14):e2111804119. PubMed ID: 35353625 [TBL] [Abstract][Full Text] [Related]
45. CCR1 antagonist J-113863 corrects the imbalance of pro- and anti-inflammatory cytokines in a SJL/J mouse model of relapsing-remitting multiple sclerosis. Ansari MA; Nadeem A; Attia SM; Bakheet SA; Shahid M; Rehman MU; Alanazi MM; Alhamed AS; Ibrahim KE; Albekairi NA; Ahmad SF Immunobiology; 2022 Sep; 227(5):152245. PubMed ID: 35868215 [TBL] [Abstract][Full Text] [Related]
46. CC chemokine receptor 4 is required for experimental autoimmune encephalomyelitis by regulating GM-CSF and IL-23 production in dendritic cells. Poppensieker K; Otte DM; Schürmann B; Limmer A; Dresing P; Drews E; Schumak B; Klotz L; Raasch J; Mildner A; Waisman A; Scheu S; Knolle P; Förster I; Prinz M; Maier W; Zimmer A; Alferink J Proc Natl Acad Sci U S A; 2012 Mar; 109(10):3897-902. PubMed ID: 22355103 [TBL] [Abstract][Full Text] [Related]
47. High Dimensional Cytometry of Central Nervous System Leukocytes During Neuroinflammation. Mrdjen D; Hartmann FJ; Becher B Methods Mol Biol; 2017; 1559():321-332. PubMed ID: 28063054 [TBL] [Abstract][Full Text] [Related]
48. Depletion of CD4+ CD25+ regulatory T cells confers susceptibility to experimental autoimmune encephalomyelitis (EAE) in GM-CSF-deficient Csf2-/- mice. Ghosh D; Curtis AD; Wilkinson DS; Mannie MD J Leukoc Biol; 2016 Oct; 100(4):747-760. PubMed ID: 27256565 [TBL] [Abstract][Full Text] [Related]
49. Myeloid sphingosine-1-phosphate receptor 1 is important for CNS autoimmunity and neuroinflammation. Tsai HC; Nguyen K; Hashemi E; Engleman E; Hla T; Han MH J Autoimmun; 2019 Dec; 105():102290. PubMed ID: 31202617 [TBL] [Abstract][Full Text] [Related]
50. Neutrophils amplify autoimmune central nervous system infiltrates by maturing local APCs. Steinbach K; Piedavent M; Bauer S; Neumann JT; Friese MA J Immunol; 2013 Nov; 191(9):4531-9. PubMed ID: 24062488 [TBL] [Abstract][Full Text] [Related]
51. GM-CSF Promotes the Survival of Peripheral-Derived Myeloid Cells in the Central Nervous System for Pain-Induced Relapse of Neuroinflammation. Matsuyama S; Yamamoto R; Murakami K; Takahashi N; Nishi R; Ishii A; Nio-Kobayashi J; Abe N; Tanaka K; Jiang JJ; Kawamoto T; Iwanaga T; Shinohara Y; Yamasaki T; Ohki I; Hojyo S; Hasebe R; Kubota SI; Hirata N; Kamimura D; Hashimoto S; Tanaka Y; Murakami M J Immunol; 2023 Jul; 211(1):34-42. PubMed ID: 37212607 [TBL] [Abstract][Full Text] [Related]
52. Hematopoietic stem/progenitor cell differentiation towards myeloid lineage is modulated by LIGHT/LIGHT receptor signaling. Chen W; Lv X; Liu C; Chen R; Liu J; Dai H; Zou GM J Cell Physiol; 2018 Feb; 233(2):1095-1103. PubMed ID: 28422285 [TBL] [Abstract][Full Text] [Related]
53. Anti-CD48 Monoclonal Antibody Attenuates Experimental Autoimmune Encephalomyelitis by Limiting the Number of Pathogenic CD4+ T Cells. McArdel SL; Brown DR; Sobel RA; Sharpe AH J Immunol; 2016 Oct; 197(8):3038-3048. PubMed ID: 27581174 [TBL] [Abstract][Full Text] [Related]
54. GM-CSF: An immune modulatory cytokine that can suppress autoimmunity. Bhattacharya P; Thiruppathi M; Elshabrawy HA; Alharshawi K; Kumar P; Prabhakar BS Cytokine; 2015 Oct; 75(2):261-71. PubMed ID: 26113402 [TBL] [Abstract][Full Text] [Related]
55. Early treatment with anti-VLA-4 mAb can prevent the infiltration and/or development of pathogenic CD11b+CD4+ T cells in the CNS during progressive EAE. Mindur JE; Ito N; Dhib-Jalbut S; Ito K PLoS One; 2014; 9(6):e99068. PubMed ID: 24896098 [TBL] [Abstract][Full Text] [Related]
56. G protein-coupled receptor kinase 2 in multiple sclerosis and experimental autoimmune encephalomyelitis. Vroon A; Kavelaars A; Limmroth V; Lombardi MS; Goebel MU; Van Dam AM; Caron MG; Schedlowski M; Heijnen CJ J Immunol; 2005 Apr; 174(7):4400-6. PubMed ID: 15778405 [TBL] [Abstract][Full Text] [Related]
57. Monoclonal antibody therapy in experimental allergic encephalomyelitis and multiple sclerosis. Zhang X; Hupperts R; De Baets M Immunol Res; 2003; 28(1):61-78. PubMed ID: 12947225 [TBL] [Abstract][Full Text] [Related]